Targeted introduction of substances into the lymph nodes for endolymphatic therapy.
Hirnle
Peter
P
Central Academic Hospital, Department of Radiation Oncology, Bielefeld, Germany.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002626:Chemistry, Pharmaceutical; D004337:Drug Carriers; D006801:Humans; D007272:Injections, Intralymphatic; D008081:Liposomes; D008198:Lymph Nodes / Q000187:drug effects*; D008207:Lymphatic Metastasis / Q000473:pathology
D000970:Antineoplastic Agents; D004337:Drug Carriers; D008081:Liposomes